“The challenge with leukemia is that its symptoms which include loss of appetite, persistent fatigue, bone pain, recurrent infections, unexplained weight loss and, easy bruising and bleeding are often overlooked or mistaken for other conditions. If such signs persist, immediate medical consultation is critical. With innovations like CAR-T Cell Therapy and targeted therapies, we’re not just treating cancer, we’re curing it. At HCGMCC, we’ve made these therapies accessible so patients in Nashik don’t have to travel to metros for world-class care,” says Dr Priyatesh Dwivedi, Hemato-oncology and BMT Specialist, HCGMCC.

Accurate diagnosis is key. Common tests include complete blood counts, peripheral blood smears, bone marrow biopsies, imaging scans, flow cytometry and molecular tests. At HCGMCC, specialists combine these with advanced technologies to ensure precise staging and treatment planning.

“Thanks to breakthroughs in targeted and immune therapies and wider adoption of stem cell transplants, many patients are now able to lead longer and healthier lives after treatment. Our mission is to bring these global advancements locally, ensuring that patients in tier 2 and tier 3 cities like Nashik have access to world-class care,” adds Dr Dwivedi.

Treatment options for leukemia have significantly advanced and include Chemotherapy, Radiation therapy, Targeted therapy, Immunotherapy, Stem cell transplants and CAR-T Cell Therapy.

“This World Leukemia Day calls for greater public awareness and proactive screening. By bridging global medical innovations with local access, we continue to redefine cancer care in India,” concludes Dr Dwivedi.

Leukemia accounts for a significant proportion of blood cancers worldwide. The common risk factors include family history, smoking and tobacco use, genetic disorders, exposure to harmful chemicals and radiation. Early detection and timely treatment significantly improve survival rates.

About HCG Manavata Cancer Centre (HCGMCC): -

Established in 2007 by Dr Raj Nagarkar, HCGMCC – Nashik is Central India's first NABH-accredited facility. With over 54 consultant oncologists, 900 staff members and a 275-bed capacity, HCGMCC is a leading institution, offering holistic cancer treatment. Specializing in surgical, radiation and medical oncology, the centre has conducted 95,000 surgeries, including 1,600 plus robotic-assisted procedures. Patient-centric and multidisciplinary, HCGMCC recommends treatments to individual needs. Beyond clinical excellence, the centre’s financial aid programs underscore its commitment to accessibility and community well-being, redefining cancer care in the pursuit of a cancer-free future.